Home Cart Sign in  
Chemical Structure| 1190221-43-2 Chemical Structure| 1190221-43-2

Structure of TM5441
CAS No.: 1190221-43-2

Chemical Structure| 1190221-43-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TM-5441 is a plasminogen activator inhibitor-1 (PAI-1) which shows inhibitory effect on several tumor cell lines with IC50 of 9.7 μM- 60.3 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TM5441

CAS No. :1190221-43-2
Formula : C21H17ClN2O6
M.W : 428.82
SMILES Code : O=C(O)C1=CC(Cl)=CC=C1NC(COCC(NC2=CC=CC(C3=COC=C3)=C2)=O)=O
MDL No. :MFCD31382187
InChI Key :BGGMLMAPVODXAU-UHFFFAOYSA-N
Pubchem ID :44250349

Safety of TM5441

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HGPS fibroblasts 10 µM 10 days TM5441 treatment restored the proliferative potential of HGPS human fibroblasts, mitigated senescence, and lowered DNA damage signaling. Cell Death Dis. 2022 Aug 26;13(8):737
Mouse brain endothelial cells (bEnd.3) 10 µM 24 hours TM5441 treatment enhanced angiogenic properties of bEnd.3 cells, as evidenced by increased total tube length, number of nodes, number of junctions, and number of meshes. Mol Ther Nucleic Acids. 2023 Jan 2;31:276-292
Mouse primary brain microvascular endothelial cells (pMBMECs) 10 µM 24 hours TM5441 treatment enhanced angiogenic properties of pMBMECs, as evidenced by increased total tube length, number of nodes, number of junctions, and number of meshes. Mol Ther Nucleic Acids. 2023 Jan 2;31:276-292
HUVEC 50 µM 24 hours To test the effect of TM5441 on endothelial cell branching, results showed that TM5441 significantly inhibited the branching of HUVEC. PLoS One. 2015 Jul 24;10(7):e0133786
Mouse proximal tubular epithelial (mProx24) cells 10 µM 4 hours Inhibited PAI-1-induced mRNA expression of fibrosis and inflammation markers and reversed PAI-1-induced inhibition of plasmin activity PLoS One. 2016 Jun 3;11(6):e0157012
HCT116 9.7-60.3 µM (IC50) 48 hours To test the effect of TM5441 on cell viability, results showed that TM5441 significantly reduced the viability of HCT116 cells. PLoS One. 2015 Jul 24;10(7):e0133786
HT1080 9.7-60.3 µM (IC50) 48 hours To test the effect of TM5441 on cell viability, results showed that TM5441 significantly reduced the viability of HT1080 cells. PLoS One. 2015 Jul 24;10(7):e0133786
C2C12 myoblasts 0.5 µM short-term and long-term treatment TM5441 inhibits PAI-1, alleviates muscle atrophy, and improves survival rate in GBM patients after radiotherapy. Cells. 2022 Oct 1;11(19):3102

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Streptozotocin (STZ)-induced diabetic model Oral 10 mg/kg/day Once daily for 16 weeks Evaluated the renoprotective effects of TM5441 in diabetic kidney injury, showing effective inhibition of albuminuria, mesangial expansion, ECM accumulation, and macrophage infiltration PLoS One. 2016 Jun 3;11(6):e0157012
Mice Kl/kl mice Oral 100 mg/kg/day Once daily TM5441 prolonged the lifespan of kl/kl mice, reduced the expression of senescence markers, and preserved organ structure and function. Proc Natl Acad Sci U S A. 2014 May 13;111(19):7090-5
Mice High-fat diet-induced obesity model Oral 15 mg/kg/day Once daily for 35 days TM5441 treatment significantly suppressed high-fat diet-induced body weight gain, improved leptin sensitivity, and upregulated thermogenesis-related gene expressions in brown adipose tissue. Front Pharmacol. 2020 Jun 24;11:943
BALB/c athymic nude mice GBM orthotopic xenograft model Oral gavage 20 mg/kg 5 times TM5441 inhibits PAI-1, alleviates muscle atrophy, and improves survival rate in GBM patients after radiotherapy. Cells. 2022 Oct 1;11(19):3102
C57BL/6J mice High-fat diet-induced obesity model Oral gavage 20 mg/kg Once daily for 10 weeks TM5441 prevented HFD-induced body weight gain and systemic insulin resistance, and improved adipocyte function Br J Pharmacol. 2016 Sep;173(17):2622-32
Mice HT1080 and HCT116 xenograft models Oral 20 mg/kg Once daily for 16-30 days To test the effect of TM5441 on tumor growth and vasculature, results showed that TM5441 increased tumor cell apoptosis and significantly disrupted tumor vasculature. PLoS One. 2015 Jul 24;10(7):e0133786
C57BL/6J mice L-NAME-induced hypertension and vascular senescence model Oral 20 mg/kg/day Daily administration for 8 weeks TM5441 attenuated L-NAME-induced hypertension, cardiac hypertrophy, and periaortic fibrosis, and prevented the increase in vascular senescence markers p16Ink4a expression and telomere length shortening. Circulation. 2013 Nov 19;128(21):2318-24
Mice High-fat/high-cholesterol high-sugar (HFHS) diet or methionine- and choline-deficient (MCD) diet-induced steatohepatitis with fibrosis Oral 20 mg/kg/day Continued for 8 weeks (MCD diet) or 16 weeks (HFHS diet) TM5441 effectively attenuates diet-induced obesity and hepatic steatosis but does not prevent NASH-related fibrosis in mice Hepatol Commun. 2018 Sep 26;2(12):1479-1492
C57BL/6J mice High-fat, high-sugar diet-induced obesity model Dietary addition 20 mg/kg/day Continued for 8 weeks TM5441 significantly attenuated weight gain in obese mice, improved hepatic steatosis, and reduced adipose tissue inflammation. Obesity (Silver Spring). 2021 Apr;29(4):713-720
Spontaneously hypertensive rats (SHR) Middle cerebral artery occlusion (MCAO) model Intravenous injection 5 mg/kg Single dose, 10 minutes before reperfusion TM5441 reduced acute brain injury volume in both young and aged SHR, increased collateral perfusion, and dilated leptomeningeal anastomotic arterioles (LMAs) through an NO-dependent mechanism. Stroke. 2018 Aug;49(8):1969-1976
Mice (C57BL/6) Middle cerebral artery occlusion (MCAO) model Intravenous injection 5 mg/kg Single dose, 15 minutes before reperfusion TM5441 significantly increased cerebrovascular blood flow at the stroke-affected site, reduced brain injury, and improved functional recovery post-stroke. Mol Ther Nucleic Acids. 2023 Jan 2;31:276-292
Rats Spontaneously hypertensive rats (SHRs) and Wistar rats Intravenous injection 5 mg/kg 10-minute infusion TM5441 modestly increased cerebral blood flow (CBF) in SHRs but not in Wistar rats, and it did not have a beneficial effect on stroke outcomes. Front Neurol. 2024 Mar 21;15:1373445
Mice UM-HET3 mice Oral 60 ppm Starting at age 11 months Evaluate the effect of TM5441 on lifespan, no significant effect observed Aging Cell. 2019 Jun;18(3):e12953

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.33mL

0.47mL

0.23mL

11.66mL

2.33mL

1.17mL

23.32mL

4.66mL

2.33mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories